Start-Up Previews (02/01)
Executive Summary
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, Proteomics, features profiles of Integrative Proteomics Inc. and Syrrx Inc. Plus these selected Start-Ups across Health Care: Emageon Inc., Embolic Protection Inc., Genosis Ltd., invivodata inc. and TheraMed Inc.
You may also be interested in...
J&J’s Talc Subsidiary Not ‘Financially Distressed’ Enough For Bankruptcy – Third Circuit
The J&J company holding the firm’s liabilities relating to talc litigation, which declared bankruptcy in 2021 shortly after its formation, had its Chapter 11 petition denied by the Third Circuit on 30 January. Attorneys weigh in on the implications for J&J and wider industry.
COVID-19 Vaccine Strain Updates Don’t Exactly Fit Flu Model
Manufacturers have different production timelines and US FDA advisory committee members worry a June strain selection may not fit the timing of COVID-19 case surges.
Lundbeck Ready To Funnel 2022 Growth Into Expected Alzheimer’s Agitation Launch
The Danish firm’s four key products yielded 31% sales growth in 2022, and the company is investing in the anticipated mid-year launch of an Alzheimer’s agitation indication for Rexulti.